These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9782204)

  • 1. Use of antisense vectors and oligodeoxynucleotides in neuro-oncology.
    Engelhard HH; Egli M; Rozental JM
    Pediatr Neurosurg; 1998 Jun; 28(6):279-85. PubMed ID: 9782204
    [No Abstract]   [Full Text] [Related]  

  • 2. Making sense of antisense.
    Murakami A
    Trends Mol Med; 2001 Oct; 7(10):430-1. PubMed ID: 11597507
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA combination therapy to stop tumor growth.
    Wickstrom E; Smith JB
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S43-7. PubMed ID: 9619270
    [No Abstract]   [Full Text] [Related]  

  • 4. Antisense technology for cancer therapy: does it make sense?
    Carter G; Lemoine NR
    Br J Cancer; 1993 May; 67(5):869-76. PubMed ID: 8494718
    [No Abstract]   [Full Text] [Related]  

  • 5. New approaches in brain tumor therapy using gene transfer and antisense oligonucleotides.
    Yung WK
    Curr Opin Oncol; 1994 May; 6(3):235-9. PubMed ID: 8080851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The application of antisense technology in ophthalmology].
    Guo Y; Ge J
    Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene therapy for brain tumors: antitumor effects of introduction of antisense and tumor suppressor gene (series 2)].
    Nitta T
    No Shinkei Geka; 1994 Oct; 22(10):903-9. PubMed ID: 7969756
    [No Abstract]   [Full Text] [Related]  

  • 8. [Approach to human glioma cells using antisense molecules].
    Yoshida S; Tanaka R
    No To Shinkei; 1995 Sep; 47(9):823-8. PubMed ID: 7546930
    [No Abstract]   [Full Text] [Related]  

  • 9. The therapeutic potential of antisense oligonucleotides.
    Sharma HW; Narayanan R
    Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles.
    Schneider T; Becker A; Ringe K; Reinhold A; Firsching R; Sabel BA
    J Neuroimmunol; 2008 Mar; 195(1-2):21-7. PubMed ID: 18304655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense therapeutics.
    Holt J
    Mol Med Today; 1996 May; 2(5):184-5. PubMed ID: 8796885
    [No Abstract]   [Full Text] [Related]  

  • 12. Antisense approaches to cancer gene therapy.
    Mercola D; Cohen JS
    Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense and sensibility.
    Dove A
    Nat Biotechnol; 2002 Feb; 20(2):121-4. PubMed ID: 11821852
    [No Abstract]   [Full Text] [Related]  

  • 14. TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors.
    Liu Y; Wang Q; Kleinschmidt-DeMasters BK; Franzusoff A; Ng KY; Lillehei KO
    J Neurooncol; 2007 Jan; 81(2):149-62. PubMed ID: 16941073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense tumor therapy (a dream under construction).
    Kopper L; Kovalszky I
    In Vivo; 1994; 8(5):781-6. PubMed ID: 7727725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotides as therapeutic agents.
    Alama A; Barbieri F; Cagnoli M; Schettini G
    Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential use of radiolabeled antisense oligonucleotides in oncology.
    Gauchez AS; Du Moulinet D'Hardemare A; Lunardi J; Vuillez JP; Fagret D
    Anticancer Res; 1999; 19(6B):4989-97. PubMed ID: 10697501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense therapy in oncology: new hope for an old idea?
    Tamm I; Dörken B; Hartmann G
    Lancet; 2001 Aug; 358(9280):489-97. PubMed ID: 11513935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense inhibition of the renin-angiotensin system in brain and peripheral organs.
    Mohuczy D; Phillips MI
    Methods; 2000 Nov; 22(3):197-209. PubMed ID: 11071815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense DNAs as targeted therapeutics for cancer: no longer a dream.
    Cho-Chung YS
    Curr Opin Investig Drugs; 2002 Jun; 3(6):934-9. PubMed ID: 12137417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.